Research progress of esophageal collision tumor

Abstract

Abstract:Esophageal collision tumor is an extremely rare tumor which defined as the concrescence of two distinct primary neoplasms. The pathobiological mechanism of collision tumors is yet to be understood. Clinical symptoms, endoscopic examination and imaging are all lack of specificity. Diagnosing a collision tumor prior to surgery is difficult. Careful pathological examination is crucial for accurately diagnosing the neoplasms in a collision tumor and ensuring appropriate management and a favorable prognosis. Esophageal collision tumors have been increasingly reported in recent years. With the aim of improving the knowledge level of esophageal collision tumor, the clinical and pathological features of this tumor is needed to be summarized.

Key words:Esophageal neoplasms,Diagnosis,Therapy,Collision tumor

Wang Hongliang, Sun Yaxin, Li Jiamei, Lin Xiaoya. Research progress of esophageal collision tumor[J]. Journal of International Oncology, 2017, 44(3): 221-223.

References

［1］ Rustgi AK, ElSerag HB. Esophageal carcinoma［J］. N Engl J Med, 2014, 371(26): 2499-2509. DOI: 10.1056/NEJMra1314530. ［2］ Yazｌcｌ O, Aksoy S, zhamam EU, et al. Squamous cell and neuroendocrine carcinoma of esophagus: collision versus composite tumor: a case report and review of literature［J］. Indian J Cancer, 2015, 52(4): 603-604. DOI: 10.4103/0019509X.178436. ［3］ Yao B, Guan S, Huang X, et al. A collision tumor of esophagus［J］. Int J Clin Exp Pathol, 2015, 8(11): 1514315146. ［4］ Sun X, Zou Y, Hao Y, et al. Pathological analysis of collision (double primary) cancer in the upper digestive tract concomitant with gastric stromal tumor: a case report［J］. Int J Clin Exp Pathol, 2015, 8 (10): 13523-13527. ［5］ Yang L, Sun X, Zou Y, et al. Small cell type neuroendocrine carcinoma colliding with squamous cell carcinoma at esophagus［J］. Int J Clin Exp Pathol, 2014, 7(4): 1792-1795. ［6］ Wang L, Zhan C, Ma J, et al. Collision tumor of esophagus: report of three cases［J］. Ann Thorac Surg, 2014, 97(3): 1075-1077. DOI: 10.1016/j.athoracsur.2013.06.090. ［7］ Li J, Chen X, Shen Y, et al. A rare collision tumor of squamous carcinoma and small cell carcinoma in esophagus involved with separate lymph nodes: a case report［J］. J Thorac Dis, 2013, 5(5): E203-206. DOI: 10.3978/j.issn.20721439.2013.09.13. ［8］ Sasaki S, Hatanaka K, Sahara N, et al. Collision tumor of primary malignant lymphoma and adenocarcinoma in the colon: report of a case［J］. Surg Today, 2010, 40(10): 975-981. DOI: 10.1007/s0059500941667. ［9］ Kato M, Nishida T, Tsutsui S, et al. Collision tumor of a carcinoid and carcinoma in the rectum［J］. Nihon Shokakibyo Gakkai Zasshi, 2010, 107(1): 61-69. ［10］赵园园, 郗彦凤, 王丽霞. 硬化性血管瘤与鳞状细胞癌碰撞于同一肺叶1例［J ］. 临床与实验病理学杂志, 2015, 31(8): 956-957. DOI: 10.13315/j.cnki.cjcep.2015.08.038. ［11］ Jang KS, Lee WM, Kim YJ, et al. Collision of three histologically distinct endometrial cancers of the uterus［J］. J Korean Med Sci, 2012, 27(1): 89-92. DOI: 10.3346/jkms.2012.27.1.89. ［12］ Fulciniti F, Vuttariello E, Calise C, et al. Combined papillary and mucoepidermoid carcinoma of the thyroid gland: a possible collision tumor diagnosed on fineneedle cytology. Report of a case with immunocytochemical and molecular correlations［J］. Endocr Pathol, 2015, 26(2): 140-144. DOI: 10.1007/s1202201593649. ［13］ Alhanafy AM, AlSharaky D, Abdou AG, et al. Metastatic collision tumour (papillary thyroid carcinoma and squamous cell carcinoma) in cervical lymph nodes: an immunohistochemical analysis［J］. J Clin Diagn Res, 2016, 10(2): ED11-13. DOI: 10.7860/JCDR/2016/16664.7263. ［14］路平, 康筱玲, 虞积耀, 等. 直肠淋巴瘤与腺癌形成的碰撞瘤临床病理观察［ J］. 诊断病理学杂志, 2012, 19(2): 111-114. DOI: 10.3969/j.issn.10078096.2012.02.012. ［15］邹宗楷, 苏海燕, 沈洪武, 等. 胃腺癌与淋巴瘤形成的碰撞瘤伴胃肠道间质瘤临床及病理观察［J］. 实用临床医学, 2014, 15(5): 12-17. DOI: 10.13764/j.cnki.lcsy.2014.05.004. ［16］贾乐, 姚志刚, 冯吉贞, 等. 食管碰撞瘤临床影像及病理分析［J］. 医学影像学杂志, 2016, 26(6): 1029-1023. ［17］ Kim VM, Goicochea L, Fang SH. Case report: collision tumour of colon leiomyosarcoma and adenocarcinoma［J］. J Clin Diagn Res, 2016, 10(6): PD03 -04. DOI: 10.7860/JCDR/2016/16949.7956. ［18］ Qian T, Gao F, Chen MZ, et al. Collision tumor of the esophagus: report of a case with mixed squamous cell carcinoma and gastrointestinal stromal tumor［J］. Int J Clin Exp Pathol, 2014, 7(3): 1206-1211. ［19］申耀元, 崔晓兵, 李曼, 等. 食管小细胞癌伴高分化鳞癌1例并文献复习［J］ . 农垦医学杂志, 2014, 36(2): 106-108. ［20］ Kim JH. Torsion of collision tumor: dermoid cyst and fibrothecoma with postmenopausal bleeding［J］. J Menopausal Med, 2016, 22(2): 114-117. DOI: 10.6118/jmm.2016.22.2.114. ［21］ Kaneko H, Miyake A, Ishii Y, et al. Case of a tumor comprising gastric cancer and duodenal neuroendocrine tumor［J］. World J Gastroenterol, 2016, 22(36): 8242-8246. DOI: 10.3748/wjg.v22.i36.8242. ［22］ Li Y, Dai M, Chang X, et al. Mixed serous neuroendocrine neoplasm of the pancreas: case report and literature review［J］. Medicine (Baltimore), 2016, 95(34): e4205. DOI: 10.1097/MD.0000000000004205. ［23］ Sasaki Y, Harada M, Kurosaki S, et al. A case of adenosquamous carcinoma at the esophagogastric junction, initially diagnosed as collision carcinoma［J］. Nihon Shokakibyo Gakkai Zasshi, 2015, 112(5): 848-855. DOI: 10.11405/nisshoshi.112.848. ［24］李明信, 陈晓东, 陈育鸿, 等. 结直肠碰撞瘤1例及文献复习［J］. 疑难病杂志, 2015, 14(1): 4953. DOI: 10.3969/j.issn.16716450.2015.01.015. ［25］ Jang KS, Lee WM, Kim YJ, et al. Collision of three histologically distinct endometrial cancers of the uterus［J］. J Korean Med Sci, 2012, 27(1): 89-92. DOI: 10.3346/jkms.2012.27.1.89. ［26］ Fukunaga H, Asama H, Kaneda H, et al. Collision tumor with diffuse large B cell lymphoma and gastric cancer［J］. Jpn J Clin Oncol, 2016, 46 (10): 968-969. DOI: 10.1093/jjco/hyw084. ［27］ Cornejo KM, Deng AC. Malignant melanoma within squamous cell carcinoma and basal cell carcinoma: is it a combined or collision tumor?—a case report and review of the literature［J］. Am J Dermatopathol, 2013, 35(2): 226-234. DOI: 10.1097/DAD.0b013e3182545e27. ［28］李慧, 李雷, 唐霄. 子宫颈碰撞癌13例临床病理分析［J］. 中华病理学杂志, 2014, 43(9): 627-628. DOI: 10.3760/cma.j.issn.05295807.2014.09.013.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma： a real-world clinical study[J]. Journal of International Oncology, 2024, 51(6): 326-331.
[3]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[4]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[5]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[6]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[7]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[8]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[9]	Fan Zhipeng, Yu Jing, Hu Jing, Liao Zhengkai, Xu Yu, Ouyang Wen, Xie Conghua.Predictive value of changes in inflammatory markers for prognosis in patients with advanced non-small cell lung cancer treated with the first-line immunotherapy plus chemotherapy[J]. Journal of International Oncology, 2024, 51(5): 257-266.
[10]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[11]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[12]	Chen Qi, Xu Chenyang, Wang Yin, Lei Dapeng.Current application status of hyperspectral imaging in the diagnosis and treatment of head and neck tumor[J]. Journal of International Oncology, 2024, 51(5): 298-302.
[13]	Wang Peixin, Zhao Jun, Xu Shihong, Jiang Zhaoyang, Wang Xiaoqiang, Yang Hongjuan.Progress of ferroptosis-related mechanisms in osteosarcoma[J]. Journal of International Oncology, 2024, 51(5): 308-311.
[14]	Wan Fang, Yang Gang, Li Rui, Wan Qijing.Expression levels and clinical significance of serum miR-497 and miR-383 in patients with esophageal cancer[J]. Journal of International Oncology, 2024, 51(4): 204-209.
[15]	Yang Hao, Shi Guidong, Zhang Chengcheng, Zhang Yue, Zhang Liwen, Fu Maoyong.Comparison of efficacy and safety between sintilimab and tislelizumab in neoadjuvant therapy for advanced esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(4): 210-216.